Maecenas pulvinar magna sit amet felis fringilla, nec auctor lectus facilisis. Morbi non velit lectus. Proin velit ex, lacinia at hendrerit ut, cursus sit amet eros. Nulla nec tellus imperdiet, ultrices quam eget, vulputate enim. Cras sed mi at felis porta lobortis et in lacus. Maecenas ac volutpat eros. Maecenas efficitur tellus semper congue ullamcorper. Etiam vulputate metus in efficitur porta. Phasellus non velit ut diam blandit suscipit. Suspendisse tristique facilisis tortor, ut ultrices arcu bibendum at. Quisque accumsan dui dictum, semper massa non, porttitor odio. Nulla sit amet enim neque. Donec magna risus, suscipit ut porttitor quis, hendrerit in purus. Vestibulum velit lorem, bibendum quis semper eu, facilisis vitae mi. Nam eget pellentesque lectus, et hendrerit metus. Maecenas non tristique tortor.
Timely insights and analysis from KFF staff
-
The latest KFF Health Tracking Poll shows that Secretary Kennedy continues to be popular among President Trump’s MAGA base and somewhat popular among supporters of his Make America Healthy Again (MAHA) movement, but his appeal beyond those two groups is limited. more
-
Extending the short-term GLP-1 Bridge program is good news for eligible Medicare beneficiaries because it provides the certainty of obesity drug coverage at a $50 copay for a longer duration, but federal spending will also rise by some unknown amount since CMS hasn’t disclosed the projected cost. more
-
Despite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to… more
Liz Hamel 
Juliette Cubanski 
Laurie Sobel